KURA NASDAQ
Kura Oncology, Inc.
1W: -13.4%
1M: +14.6%
3M: +28.6%
YTD: +10.2%
1Y: +39.4%
3Y: +17.9%
5Y: -40.5%
$11.39
-0.18 (-1.56%)
Weekly Expected Move ±10.4%
$9
$10
$11
$13
$14
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$2.4M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.0B
52W Range7.358-13.9
Volume2,117,010
Avg Volume1,850,563
Beta0.38
Dividend—
Analyst Ratings
Company Info
CEOTroy Wilson
Employees260
SectorHealthcare
IndustryBiotechnology
IPO Date2015-09-16
Websitekuraoncology.com
4930 Directors Place
San Diego, CA 92121
US
San Diego, CA 92121
US
858 500 8800
About Kura Oncology, Inc.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The companyâs first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Latest News
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
Kura Oncology appoints Jennifer Fulk as CFO
Legal & General Group Plc Purchases Shares of 61,444 Kura Oncology, Inc. $KURA
Bank of New York Mellon Corp Makes New $2.83 Million Investment in Kura Oncology, Inc. $KURA
KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Fulk Jennifer | A-Award | 450,000 | $12.52 | 2026-09-08 |
| Fulk Jennifer | 0 | — | 2026-09-08 | |
| WILSON TROY EDWARD | P-Purchase | 100,000 | $12.39 | 2026-08-24 |
| Powl Brian T. | S-Sale | 4,345 | $11.89 | 2026-08-21 |
| Bair Teresa Brophy | S-Sale | 31,487 | $12.63 | 2026-08-19 |